CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI)

CUSIP: 163572209

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / COM NEW
Total 13F shares
1,424,720
Share change
0
Total reported value
$4,800,000
Price per share
$3.36
Number of holders
16

Quarterly Holders Quick Answers

What is CUSIP 163572209?
CUSIP 163572209 identifies CEMI - CHEMBIO DIAGNOSTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) as of Q4 2013

As of 31 Dec 2013, CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) was held by 16 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,424,720 shares. The largest 10 holders included WELLINGTON MANAGEMENT CO LLP, WASATCH ADVISORS INC, VANGUARD GROUP INC, HealthInvest Partners AB, Stanley-Laman Group, Ltd., DAFNA Capital Management LLC, Phocas Financial Corp., Creative Planning, Spark Investment Management LLC, and FRANKLIN STREET ADVISORS INC /NC. This page lists 16 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.